Science ❯ Medical Research ❯ Clinical Trials

Drug Efficacy

Neurological Disorders Long-acting Treatments Weight Loss Treatments GLP-1 Receptor Agonists Cardiovascular Disease Research HIV Research Public Health Alzheimer's Research Health Outcomes HIV Treatment Innovations Safety Assessments GLP-1 Injections Preventive Medicine Neuroscience

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

The purchase marks Pfizer’s pivot toward cardiometabolic drugs following setbacks in its oral GLP‑1 program.